Welcome to our dedicated page for National Vision SEC filings (Ticker: EYE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From low-cost eye exams at America’s Best to Vision Centers hosted inside Walmart, National Vision’s growth story lives inside its SEC disclosures. We bring every National Vision SEC filing explained simply, turning hundreds of optical-retail pages into clear takeaways you can act on.
Need the numbers fast? Our AI-powered summaries break down —
- National Vision quarterly earnings report 10-Q filing: store-level comps, lens lab capacity and managed-care mix.
- National Vision annual report 10-K simplified: segment margins, lease obligations and clinic expansion risks.
- National Vision 8-K material events explained: partner renewals, leadership changes and unexpected disruptions.
- National Vision insider trading Form 4 transactions with real-time alerts, plus a complete log of National Vision executive stock transactions Form 4.
- National Vision proxy statement executive compensation insights, including optometrist incentive structures.
Every document hits our site the moment it posts to EDGAR, so National Vision Form 4 insider transactions real-time alerts arrive before the market digests them. Interactive charts and plain-English notes support understanding National Vision SEC documents with AI, letting you compare eyewear unit economics across quarters or perform National Vision earnings report filing analysis without sifting through footnotes.
Whether you’re monitoring optical retail trends, verifying compliance metrics, or watching National Vision insider trading Form 4 transactions, our platform gives you the clarity and speed needed to make informed decisions.
National Vision Holdings, Inc. (EYE) filed a Form 144 indicating a proposed sale of 137,400 common shares to be executed through Fidelity Brokerage Services LLC. The filing shows an aggregate market value of $3,343,335.27 and reports 79,196,383 shares outstanding for the issuer, with an approximate sale date of 08/28/2025. The shares were acquired on 08/16/2021 through a stock option exercise and payment was made in cash.
The filing form lacks identifying filer contact details (CIK, submission contact name, phone, and email are not provided in the content). It also states "Nothing to Report" for securities sold during the past three months.
Wilkes Alexander, who is listed as both Chief Executive Officer and a director of National Vision Holdings, Inc. (EYE), reported transactions related to restricted stock units (RSUs) on 08/19/2025. A tranche of 61,785 RSUs vested and converted one-for-one into common stock. To satisfy tax withholding on vesting, 25,189 shares were withheld at a price of $23.61, leaving an incremental 36,596 shares delivered from the vesting. After the reported transactions, the filing shows 247,115 shares beneficially owned by the reporting person. The RSU grant that produced this vesting was originally awarded on 08/19/2024 for 185,357 RSUs, scheduled to vest in three equal annual installments. The Form 4 was signed by an attorney-in-fact.
Summary: Burgundy Asset Management Ltd. reports beneficial ownership of 2,505,978 shares of National Vision Holdings, Inc. common stock, representing 3.17% of the class. The filing states Burgundy is an investment adviser (IA) and discloses sole voting power over 1,833,858 shares and sole dispositive power over all 2,505,978 shares reported. The statement affirms the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Event: On August 1, 2025 the Board of National Vision Holdings, Inc. (NASDAQ: EYE) increased its size to eleven directors and appointed Alex Wilkes as a director effective August 1, 2025.
Context: The appointment was made in accordance with the Company's CEO succession plan previously disclosed in the Current Report on Form 8-K filed April 29, 2025. Under that plan, Reade Fahs will become Executive Chairman and Mr. Wilkes will succeed Mr. Fahs as Chief Executive Officer.
- Filing type: Form 8-K dated August 4, 2025 (earliest event reported August 1, 2025).
- Exhibit included: Exhibit 104 (Cover Page Interactive Data File - Inline XBRL).
On June 18, 2025, National Vision Holdings, Inc. (Nasdaq: EYE) held its 2025 Annual Meeting of Stockholders, with the Form 8-K filed on June 23, 2025 summarizing the certified results.
Key outcomes
- Election of Directors (Proposal 1): All eight nominees were re-elected for terms expiring at the 2026 meeting. Support levels exceeded 98% of votes cast, with Michael J. Nicholson receiving the highest approval (≈99.9% in favor).
- Say-on-Pay (Proposal 2): The advisory vote on executive compensation passed with 65.7 million votes for (≈97%) versus 2.0 million against.
- Auditor Ratification (Proposal 3): Deloitte & Touche LLP was ratified as independent registered public accounting firm for fiscal 2025 with 71.6 million votes for (≈98.7%).
No other substantive matters, financial results, or strategic transactions were reported. The filing is primarily a routine governance disclosure confirming shareholder support for the Board, executive pay program, and auditor.
FAQ
What is the current stock price of National Vision (EYE)?
What is the market cap of National Vision (EYE)?
